Rechercher dans la communauté

www.leselection.com Bon la grue est bien en place maintenant pour la phase 2... à ce qu'il parait. c'est sur le coin Carrefour et Daniel Johnson.

Louise Harel songe à la mairie Radiocanada.ca Louise Harel a admis pour la première fois qu'elle réfléchit sérieusement à la possibilité de se présenter à la mairie de Montréal. Elle a fait cette déclaration lors de son passage hier à l'émission Bons baisers de France, à la télévision de Radio-Canada. Mme Harel avoué qu'elle s'en faisait énormément parler. « J'y réfléchis en sachant qu'il y a un compte à rebours », a-t-elle déclaré. L'ancienne ministre et députée péquiste a ajouté qu'elle devait se questionner sur la faisabilité de la chose. Dans un sondage Angus Reid publié dans Le Presse le 11 mai dernier, on demandait aux Montréalais pour qui ils voteraient parmi les candidats suivants: Martin Cauchon, Denis Coderre, Jacques Duchesneau, Liza Frulla, Louise Harel, Pierre Marc Johnson, Robert Laramée et Gilbert Rozon. Mme Harel était arrivée en tête, avec 17 % des intentions de vote. Elle était suivie de Pierre Marc Johnson, avec 11 % des suffrages, Liza Frulla (9 %) et Denis Coderre (9 %). Le sondage d'Angus Reid a été mené les 6 et 7 mai auprès de 805 personnes vivant sur l'île de Montréal. La marge d'erreur est de 3,5 points.

NEW YORK (CNNMoney.com) -- Real estate values around the nation have collapsed, and sales of foreclosed and "underwater" homes now dominate many housing markets, according to a report released Tuesday. The report, from Zillow.com, a real estate Web site, revealed that with foreclosures soaring, nearly 20% of the nation's home sales in 2008 were of bank-repossessed properties. Another 11% were short sales, in which homeowners owed more in mortgage debt than their homes were worth. Madera, Calif., had the highest percentage of these distressed sales: 54.6% of all transactions there were foreclosed homes, and another 3.4% were short sales. In Merced, Calif., 53.4% of sales were foreclosures and 4.8% were short sales. In nearby Stockton, 51.1% were foreclosures and 5.4% were short sales. "As more markets turn down and markets that were already down go deeper, the pace at which value is being erased from the U.S. housing stock is rapidly increasing," said Stan Humphries, Zillow's vice president in charge of data and analytics. "More value [was] wiped out in the fourth quarter of 2008 than was eliminated in all of 2007," Humphries said. About $3.3 trillion in home equity was erased in 2008, with $1.4 trillion of that wipeout coming in the fourth quarter alone, according to Humphries. More than $6 trillion in value has been lost since the market peaked in 2005. Those equity losses have put many homeowners underwater, where they're extremely vulnerable to foreclosure. These owners can't tap home equity for the cash they need to pay bills when they run into rough financial patches, and they often find it impossible to refinance - lenders will not loan more than the property is worth. In the United States, 17.6% of all homes are now underwater, according to Zillow, as are 41.2% of all mortgages for homes bought in the past five years. The worst-hit cities are in the once-booming Sun Belt. In Las Vegas, 61.4% of all homes are underwater. Because so many homes are worth less than their mortgage balances, an increasing number have to be sold short. But short sale transactions can take a long time to complete, because lenders have been having trouble keeping up with the flood of requests. "The speed of short sales is a function of the resources being allocated to them by lenders, and those resources are being stretched to the limit," Humphries said. That means lenders may not act on approving short sales for months. The deals cannot go forward without their approval, because the banks must agree to forgive the difference between what they're owed and what the sale brings in. As the time it takes to arrange short sales lengthens, they become harder to complete. Time and money wasted One example of how price declines can doom a short sale occurred recently in Phoenix. Curtis Johnson, a real estate broker there, worked with a health care worker whose hours were being cut and who could no longer afford her mortgage. She fell behind and decided to sell. Johnson was able to find a buyer willing to pay $183,000, and got an approval form the lender. The owner confidently moved out, got a new place and started a new life. But the lender folded and the mortgage went to a new servicer, who took six weeks to approve the deal. "Unfortunately, the buyers who were approved were no longer interested because the real estate market had dropped significantly," Johnson said. "They wrote a new offer, considerably lower then the first, and it was time to start over." Two more offers eventually fell through before a new buyer was found and the owner's bank approved the price, this time at $163,000. On the day of that closing, however, the parties discovered that the buyer's lender had run out of funds and dropped out of the deal. The home went to foreclosure auction before another sale could be arranged. The house is now on the market for $139,900. "[The house is] listed for less than what would have been received had the bank been willing to work with us, and still has not yet sold," Johnson said. Distressed sales like that depress the market for all homeowners. Regular sellers in cities dominated by foreclosures have to adjust their prices downward to compete. The percentage of homes sold for less than what their owners originally paid has leaped up in the past couple of years. In the United States as a whole, 34.6% of the sales made in 2008 were done at a loss. In Merced, 71.6% of all sales last year were for less than the seller paid. Stockton, Modesto and Las Vegas all had in excess of 68% of all homes being sold at a loss. Foreclosures beget more foreclosures by adding inventory to the market, which depresses prices, which increases foreclosures, according to Humphries.

Le groupe pharmaceutique américain Johnson & Johnson a dépassé mardi les attentes du marché au quatrième trimestre 2008 et sur l'ensemble de l'année écoulée. Pour en lire plus...

La compagnie pharmaceutique américaine met la main sur un fournisseur de produits d'anesthésie. Pour en lire plus...

La compagnie américaine a dépassé les attentes au troisième trimestre et relevé une nouvelle fois ses prévisions pour l'ensemble de l'exercice. Pour en lire plus...

Le maire de Londres veut un nouvel aéroport Reuters Édition du mercredi 13 août 2008 Londres -- Boris Johnson, maire de Londres depuis mai dernier, s'est prononcé hier pour la construction d'un nouvel aéroport à l'est de la ville afin de décongestionner les cinq autres qui desservent la capitale britannique. «Il est [...] plus urgent que jamais d'étudier une solution à long terme, sous la forme d'un nouvel aéroport international respectant mieux l'environnement», écrit-il dans le Daily Telegraph. Johnson dit douter qu'un projet de troisième piste envisagé pour Heathrow -- l'aéroport le plus actif du monde avec plus de 68 millions de voyageurs par an -- soit jamais réalisé. Il souligne en outre que Gatwick, le deuxième aéroport londonien par ordre d'importance, est «plein à craquer». «Le maire tient à connaître les solutions de rechange à l'agrandissement d'Heathrow et aimerait savoir si l'idée d'un nouvel aéroport sur l'estuaire de la Tamise serait viable ou non», a indiqué à Reuters un porte-parole de Johnson. «Il a demandé à des fonctionnaires d'examiner la faisabilité d'un nouvel aéroport pour voir si cela mérite une étude approfondie», a-t-il ajouté. Johnson a aussi fait savoir qu'il serait favorable à un développement du City Airport de l'est de Londres, prisé des hommes d'affaires parce que proche des quartiers financiers. Cet aéroport, propriété du consortium American International Group et de Credit Suisse, cherche à porter sa capacité annuelle de 80 000 à 120 000 vols. Selon un porte-parole de City Airport, ce développement ne réclamerait pas de nouveaux travaux de construction. Une demande d'autorisation initiale a toutefois été différée par Johnson le mois dernier pour que l'on détermine si ce développement n'affecterait un projet de pont sur l'estuaire de la Tamise. Heathrow, Gatwick et Stansted appartiennent tous à au groupe BAA, dont la commission britannique de la Concurrence cherche à déterminer s'il doit céder l'un de ses aéroports pour ne plus être en position de monopole. BAA a pour propriétaire l'espagnol Ferrovial. La commission pourrait remettre un rapport la semaine prochaine, bien qu'aucune date ferme ne soit fixée.

Le géant américain empoche des profits de 3,3 G$ US au deuxième trimestre et hausse encore les prévisions de profits par action pour l'année. Pour en lire plus...

Prise de contrôle Fruits & Passion vendue à SC Johnson ARGENT Une autre entreprise d'origine québécoise passe aux mains d'une grande entreprise américaine. Cette fois, c'est l'entreprise de produits cosmétiques Fruits & Passion qui est vendue à SC Johnson. Fruits & Passion a été fondée en 1992 et a connu une croissance très rapide. Elle possède maintenant 2000 points de vente qui distribuent ses produits aux États-Unis, en Europe, au Moyen-Orient, et en Asie. La France et la Suisse, notamment, comptent plusieurs franchisés, de même que le Japon et l'Angleterre. Le siège social de Fruits et Passion est situé à Candiac, en banlieue de Montréal, et il compte à lui seul plus de 500 employés. http://argent.canoe.com/lca/infos/quebec/archives/2008/05/20080528-164201.html

DRAXIS To Construct Second Facility In Montreal Area November 27, 2007: 10:14 AM EST DOW JONES NEWSWIRES DRAXIS Health Inc. (DRAX) has initiated construction of a 77,000-square-foot secondary packaging and warehousing facility in the Montreal area to help it meet its obligations under its contract to produce a broad portfolio of multiple non-sterile specialty semi-solid products for Johnson & Johnson (JNJ). DRAXIS said it expects the new facility to be completed by mid-2008. The new facility is being built by Montreal developer Broccolini Construction Inc. specifically to meet the needs of DRAXIS with respect to this major contract. It will be owned by Broccolini Group of Cos. and leased to DRAXIS under a seven-year agreement with options to renew. Initially, DRAXIS plans to have about 50 employees at this second Montreal- area facility, part of the 80 to 100 employees that it will hire for this contract. The contract to produce semi-solid specialty products calls for commercial production to start in 2009 and initially run for five years to the end of 2013. DRAXIS, Mississauga, Ont., is a pharmaceutical company. -Carolyn King; 416-306-2100; AskNewswires@dowjones.com

Draxis to create up to 100 jobs after chosen by J&J for contract manufacturing 6 days ago MONTREAL (CP) — Pharma company Draxis Health Inc. (TSX:DAX) is building a new Montreal plant and hiring up to 100 people after the company's contract manufacturing division expanded its existing relationship with Johnson & Johnson, one of the world's biggest consumer products companies. The contract expansion will lead to between 80 to 100 new positions at Draxis Pharma operations in the Montreal area and require the building of a new secondary plant, in addition to the current Draxis manufacturing plant in suburban Kirkland, the company said Wednesday. On the Toronto Stock Exchange, Draxis stock jumped 34 cents to trade at $5.39, a gain of 6.7 per cent as investors reacted positively to the news. Draxis said the new deal with Johnson & Johnson Consumer Companies Inc. could mean another US$120 million in revenues over five years to the Canadian company. In addition, the transfer of equipment and production technologies, now in progress, is expected to generate additional revenues this year and next of between US$6 million and US$8 million. The supply deal, which runs to the end of 2013 and can be extended, involves the manufacturing of non-sterile specialty semi-solid products currently sold in the United States. Commercial production is expected to begin in 2009. "The signing of this contract is a reflection of the solid business model at Draxis," said Martin Barkin, president and CEO of the Toronto-area company. "We are honoured to have been selected from more than 80 international contract manufacturers under a rigorous and comprehensive global selection process conducted over an extended multi-year period. "This contract includes prescription and non-prescription products and will significantly improve capacity utilization in the semi-solids section of our non-sterile operations." As a result of the manufacturing deal, Draxis plans to build a new secondary plant to handle labeling, product assembly for different markets, cartoning and shipping. The new operation is slated to open next summer and will complement the company's production plant in Kirkland, in west-end Montreal. The jobs expansion is good news for the local Montreal economy, which has also seen other drug developers expand operations in recent months. In June, global drug giant GlaxoSmithKline (NYSE:GSK) announced it has spent $50 million to upgrade its laboratory north of Montreal into the North American research and administrative headquarters for its vaccine division. GlaxoSmithKline, based in Britain, is a world leader in the vaccine business. The company has 3,300 employees in Canada, including 1,400 in Quebec. Draxis, based in Mississauga, Ont. makes sterile products such as injectable liquids, ointments and creams, non-sterile products as well as radiopharmaceuticals for diagnostic imaging and treatment. The company employs about 500 people at its Montreal plant. Last year, Draxis generated a profit of US$11.5 million on revenues of just under US$90 million.